Nocturia Industry Research Report 2023

Report ID
34253
Publisher
APO Research
Published Date
08-Aug
Delivery Format
PDF
No of Report Page
87
Editor's Rating
US $2,950.00
US $4,425.00
US $5,900.00
  • Report Details
    Highlights
    
    The global Nocturia market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
    
    North American market for Nocturia is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
    
    Asia-Pacific market for Nocturia is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
    
    The major global companies of Nocturia include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott and Teva, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
    
    The global market for Nocturia in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
    
    Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Desmopressin, which accounted for % of the global market of Nocturia in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
    
    Report Scope
    This report aims to provide a comprehensive presentation of the global market for Nocturia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturia.
    
    The Nocturia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    
    For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
    
    The report will help the Nocturia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
    
    Key Companies & Market Share Insights
    In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
    
    Some of the prominent players reviewed in the research report include:
    
    • Astellas Pharma
    • Allergan
    • Ferring Pharmaceuticals
    • Eli Lilly
    • GlaxoSmithKline
    • Sanofi
    • Pfizer
    • Abbott
    • Teva
    • Mylan
    • Johnson & Johnson
    • Hainan Zhonghe Pharmaceutical
    Product Type Insights Global markets are presented by Nocturia type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Nocturia are procured by the companies. This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029). Nocturia segment by Type
    • Desmopressin
    • Anticholinergic Drugs
    • Alpha Blockers
    • Diuretics
    • Others
    Application Insights This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029). This report also outlines the market trends of each segment and consumer behaviors impacting the Nocturia market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Nocturia market. Nocturia Segment by Sale Channels
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    Regional Outlook This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
    • North America
    • United States
    • Canada
    • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
    • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
    • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
    • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
    Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Nocturia market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come. Reasons to Buy This Report
    • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nocturia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
    • This report will help stakeholders to understand the global industry status and trends of Nocturia and provides them with information on key market drivers, restraints, challenges, and opportunities.
    • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
    • This report stays updated with novel technology integration, features, and the latest developments in the market
    • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Nocturia industry.
    • This report helps stakeholders to gain insights into which regions to target globally
    • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nocturia.
    • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
    Core Chapters Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Nocturia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report. Frequently Asked Questions
    • What factors will challenge the Product Name market growth?
    • Which end-use segment will expand at the fastest CAGR in the Product Name market?
    • Which are the emerging players in the Product Name market?
    • How concentrated is the Product Name market?
    • Which factors are positively contributing to the Product Name market growth?
    • Which are the novel product innovations in the Product Name market?
    • Which product segment will emerge as the most lucrative in the Product Name market?
    • Which factors are increasing the competition in the Product Name market?
    • Which are the strategic measures taken by the Product Name industry players?
    • Which region will witness inactive growth during the forecast period?
    • What key trends are likely to emerge in the Product Name market in the coming years?
  • Table Of Content
    1 Preface
    1.1 Scope of Report
    1.2 Reasons for Doing This Study
    1.3 Research Methodology
    1.4 Research Process
    1.5 Data Source
    1.5.1 Secondary Sources
    1.5.2 Primary Sources
    2 Market Overview
    2.1 Product Definition
    2.2 Nocturia by Type
    2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
    1.2.2 Desmopressin
    1.2.3 Anticholinergic Drugs
    1.2.4 Alpha Blockers
    1.2.5 Diuretics
    1.2.6 Others
    2.3 Nocturia by Sale Channels
    2.3.1 Market Value Comparison by Sale Channels (2018 VS 2022 VS 2029)
    2.3.2 Hospital Pharmacies
    2.3.3 Retail Pharmacies
    2.3.4 Online Pharmacies
    2.4 Assumptions and Limitations
    3 Nocturia Breakdown Data by Type
    3.1 Global Nocturia Historic Market Size by Type (2018-2023)
    3.2 Global Nocturia Forecasted Market Size by Type (2023-2028)
    4 Nocturia Breakdown Data by Sale Channels
    4.1 Global Nocturia Historic Market Size by Sale Channels (2018-2023)
    4.2 Global Nocturia Forecasted Market Size by Sale Channels (2018-2023)
    5 Global Growth Trends
    5.1 Global Nocturia Market Perspective (2018-2029)
    5.2 Global Nocturia Growth Trends by Region
    5.2.1 Global Nocturia Market Size by Region: 2018 VS 2022 VS 2029
    5.2.2 Nocturia Historic Market Size by Region (2018-2023)
    5.2.3 Nocturia Forecasted Market Size by Region (2024-2029)
    5.3 Nocturia Market Dynamics
    5.3.1 Nocturia Industry Trends
    5.3.2 Nocturia Market Drivers
    5.3.3 Nocturia Market Challenges
    5.3.4 Nocturia Market Restraints
    6 Market Competitive Landscape by Players
    6.1 Global Top Nocturia Players by Revenue
    6.1.1 Global Top Nocturia Players by Revenue (2018-2023)
    6.1.2 Global Nocturia Revenue Market Share by Players (2018-2023)
    6.2 Global Nocturia Industry Players Ranking, 2021 VS 2022 VS 2023
    6.3 Global Key Players of Nocturia Head office and Area Served
    6.4 Global Nocturia Players, Product Type & Application
    6.5 Global Nocturia Players, Date of Enter into This Industry
    6.6 Global Nocturia Market CR5 and HHI
    6.7 Global Players Mergers & Acquisition
    7 North America
    7.1 North America Nocturia Market Size (2018-2029)
    7.2 North America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 North America Nocturia Market Size by Country (2018-2023)
    7.4 North America Nocturia Market Size by Country (2024-2029)
    7.5 United States
    7.6 Canada
    8 Europe
    8.1 Europe Nocturia Market Size (2018-2029)
    8.2 Europe Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
    8.3 Europe Nocturia Market Size by Country (2018-2023)
    8.4 Europe Nocturia Market Size by Country (2024-2029)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
    9 Asia-Pacific
    9.1 Asia-Pacific Nocturia Market Size (2018-2029)
    9.2 Asia-Pacific Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Asia-Pacific Nocturia Market Size by Country (2018-2023)
    9.4 Asia-Pacific Nocturia Market Size by Country (2024-2029)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
    10 Latin America
    10.1 Latin America Nocturia Market Size (2018-2029)
    10.2 Latin America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Latin America Nocturia Market Size by Country (2018-2023)
    10.4 Latin America Nocturia Market Size by Country (2024-2029)
    9.4 Mexico
    9.5 Brazil
    11 Middle East & Africa
    11.1 Middle East & Africa Nocturia Market Size (2018-2029)
    11.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
    11.3 Middle East & Africa Nocturia Market Size by Country (2018-2023)
    11.4 Middle East & Africa Nocturia Market Size by Country (2024-2029)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
    12 Players Profiled
    11.1 Astellas Pharma
    11.1.1 Astellas Pharma Company Detail
    11.1.2 Astellas Pharma Business Overview
    11.1.3 Astellas Pharma Nocturia Introduction
    11.1.4 Astellas Pharma Revenue in Nocturia Business (2017-2022)
    11.1.5 Astellas Pharma Recent Development
    11.2 Allergan
    11.2.1 Allergan Company Detail
    11.2.2 Allergan Business Overview
    11.2.3 Allergan Nocturia Introduction
    11.2.4 Allergan Revenue in Nocturia Business (2017-2022)
    11.2.5 Allergan Recent Development
    11.3 Ferring Pharmaceuticals
    11.3.1 Ferring Pharmaceuticals Company Detail
    11.3.2 Ferring Pharmaceuticals Business Overview
    11.3.3 Ferring Pharmaceuticals Nocturia Introduction
    11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2017-2022)
    11.3.5 Ferring Pharmaceuticals Recent Development
    11.4 Eli Lilly
    11.4.1 Eli Lilly Company Detail
    11.4.2 Eli Lilly Business Overview
    11.4.3 Eli Lilly Nocturia Introduction
    11.4.4 Eli Lilly Revenue in Nocturia Business (2017-2022)
    11.4.5 Eli Lilly Recent Development
    11.5 GlaxoSmithKline
    11.5.1 GlaxoSmithKline Company Detail
    11.5.2 GlaxoSmithKline Business Overview
    11.5.3 GlaxoSmithKline Nocturia Introduction
    11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2017-2022)
    11.5.5 GlaxoSmithKline Recent Development
    11.6 Sanofi
    11.6.1 Sanofi Company Detail
    11.6.2 Sanofi Business Overview
    11.6.3 Sanofi Nocturia Introduction
    11.6.4 Sanofi Revenue in Nocturia Business (2017-2022)
    11.6.5 Sanofi Recent Development
    11.7 Pfizer
    11.7.1 Pfizer Company Detail
    11.7.2 Pfizer Business Overview
    11.7.3 Pfizer Nocturia Introduction
    11.7.4 Pfizer Revenue in Nocturia Business (2017-2022)
    11.7.5 Pfizer Recent Development
    11.8 Abbott
    11.8.1 Abbott Company Detail
    11.8.2 Abbott Business Overview
    11.8.3 Abbott Nocturia Introduction
    11.8.4 Abbott Revenue in Nocturia Business (2017-2022)
    11.8.5 Abbott Recent Development
    11.9 Teva
    11.9.1 Teva Company Detail
    11.9.2 Teva Business Overview
    11.9.3 Teva Nocturia Introduction
    11.9.4 Teva Revenue in Nocturia Business (2017-2022)
    11.9.5 Teva Recent Development
    11.10 Mylan
    11.10.1 Mylan Company Detail
    11.10.2 Mylan Business Overview
    11.10.3 Mylan Nocturia Introduction
    11.10.4 Mylan Revenue in Nocturia Business (2017-2022)
    11.10.5 Mylan Recent Development
    11.11 Johnson & Johnson
    11.11.1 Johnson & Johnson Company Detail
    11.11.2 Johnson & Johnson Business Overview
    11.11.3 Johnson & Johnson Nocturia Introduction
    11.11.4 Johnson & Johnson Revenue in Nocturia Business (2017-2022)
    11.11.5 Johnson & Johnson Recent Development
    11.12 Hainan Zhonghe Pharmaceutical
    11.12.1 Hainan Zhonghe Pharmaceutical Company Detail
    11.12.2 Hainan Zhonghe Pharmaceutical Business Overview
    11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction
    11.12.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2017-2022)
    11.12.5 Hainan Zhonghe Pharmaceutical Recent Development
    13 Report Conclusion
    14 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
connect with us